Apollo Forms “Apollo Strategic Origination Partners” Focused on Large-Scale Direct Lending
NEW YORK, July 06, 2020 (GLOBE NEWSWIRE) — Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo” […]
IGNITE Provides an Update on the Filing of Its Q1 Financial Statements and MD&A
VAUGHAN, Ontario, July 06, 2020 (GLOBE NEWSWIRE) — IGNITE International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (“IGNITE” or the “Company”), a […]
WPD Pharmaceuticals Licensor Announces Updates on Annamycin and WP1066
VANCOUVER, British Columbia, July 06, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a […]
BetterLife Pharma (OTCB:BETRD) CEO Discusses Using Interferons to Defeat ‘Truly Evil Virus’
New York City, July 06, 2020 (GLOBE NEWSWIRE) — The CEO of BetterLife Pharma (OTCQB:BETRD) (CSE: BETR) (FRANKFURT: NPAT), an emerging […]
MPX International’s Subsidiary, Spartan Wellness, Enters Into a Services Agreement With Medical Cannabis by Shoppers Drug Mart Inc.
NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO […]
VSBLTY CEO PROVIDES CORPORATE UPDATE
Philadelphia, PA, July 06, 2020 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC:VSBGF) (“VSBLTY”), a leading security and retail […]
Indus Holdings, Inc. Responds to Rising Demand for Higher Potency Cannabis Products With New Cypress Reserve Line
Premium California-grown flower debuts at licensed dispensaries statewideLink to imagesSALINAS, Calif., July 06, 2020 (GLOBE NEWSWIRE) — With consumer demand […]
Myriad Announces Partnership with OptraHEALTH® to Deliver “Gene™” a New AI Based Information Tool for Hereditary Cancer Patients
SALT LAKE CITY, July 06, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and […]
Vir Biotechnology Announces Proposed Public Offering of Common Stock
SAN FRANCISCO, July 06, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining […]
Anavex Life Sciences Announces First Participant Enrolled in Phase 1 Study of ANAVEX®3-71 (AF710B)
NEW YORK, July 06, 2020 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]
